CARESTART™ COVID-19 ANTIGEN
SARS-CoV-2, A highly contagious novel virus, has severely impacted the global healthcare system and economy. A rapid in vitro testing is a key component to identify and mitigate the spread.
The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the SARS-CoV-2 nucleocapsid protein in nasopharyngeal and nasal swab specimens. The tests deliver results in 10 minutes without the need for a reader. The CareStart™ COVID-19 Antigen Test is manufactured by Access-Bio Inc, an industry-leading diagnostics business based in the USA.
Click image for detailed steps
Documentation related to this product is available for download here. Also, consult Apacor’s full database of References for all other product documentation and related validations and certification.